PLASMA LEVEL OF SOLUBLE CD30 IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT PATIENT
https://doi.org/10.15825/1995-1191-2011-4-37-42
Abstract
Soluble CD30 (sCD30) is a marker of T-lymphocytes activation and is used for monitoring rejection in patients after heart, lung and renal transplantation. The aim of the study was to evaluate plasma levels of sCD30 in child- ren before and after living-donor liver transplantation (LDLT) and its relationship with the postoperative course. The study included 72 children with end-stage liver disease (ESLD), aged 17 ± 11 (4–28) months before and after LDLT, 15 healthy children aged 9.9 ± 5.7 (3–21) months and 38 adult living-related liver donors, aged 37 ± 19 (18–56) years.
In children with ESLD pre-transplant plasma level of sCD30 (84,9 ± 43,8 ng/ml) was significantly higher than in healthy donors and healthy children (26.4 ± 12.0 and 32.6 ± 6.9 ng/ml, resp., p < 0.01). After LDLT plasma level of sCD30 was higher in children, who had graft dysfunction at days 28–32 (108.9 ± 17.7 ng/ml) after LDLT than in children who had no graft dysfunction (40.2 ± 5.3 ng/ml, р < 0.01). In patients with graft dysfunction elevation of sCD30 concentration was observed before 2–5 days increasing of liver enzyme activity. The measurement of sCD30 concentration may be useful for monitoring of the postoperative course.
About the Authors
O. P. Shevchenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
O. M. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
G. A. Olefirenko
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
M. E. Pishchulina
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
I. E. Tsirulnikova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
A. V. Bugrov
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
A. A. Andrianova
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
S. V. Gautier
Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow
Russian Federation
Russian Federation
References
1. Арзуманов С.В., Ватазин А.В., Москалец О.В. и со- авт. Иммунологический мониторинг и роль sCD30 в диагностике острого отторжения трансплантиро- ванной почки // Вестник трансплантологии и искус- ственных органов. 2008. 4 (42). C. 11–14.
2. Бугров А.В., Казаков Э.Н., Кормер А.Я. и соавт. Роль растворимого CD30 (sCD30) при трансплантации сердца // Материалы III Конгресса московских хи- рургов «Неотложная и специализированная хирурги- ческая помощь». Москва. 2009. С. 136–137.
3. Готье С.В., Константинов Б.А., Цирульникова О.М. Трансплантация печени // М.: Медицинское инфор- мационное агентство, 2008. 296 с
4. Готье С.В., Шевченко О.П. Новые лабораторные те- сты – новое в клинической трансплантологии // Лабо- раторная медицина в свете концепции развития здра- воохранения России до 2020 года. 2009. С. 82–94.
5. Шевченко О.П., Орлова О.В., Бугров А.В., Долгов В.В. Уровень растворимого CD30 (sCD30) в плазме кро- ви больных сердечной недостаточностью связан с отдаленным прогнозом после трансплантации серд- ца (ТС) // Вестник трансплантологии и искусствен- ных органов: Материалы IV Всероссийского съезда трансплантологов. 2008. С. 34–35.
6. Ayed K., Abdallah T.B., Bardi R. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection // Transplant Proc. 2006. Vol. 38. Р. 2300–2302.
7. Bharat A., Narayanan K., Golocheikine A. et al. Elevat- ed soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis // Transplantation. 2007. Vol. 84 (12). Р. 1704–1707.
8. Castillo F.M, Romero T.A., Estevez J. Concentrations of Cytokines, Soluble Interleukin-2 Receptor, and Soluble CD30 in Sera of Patients with Hepatitis B Virus Infec- tion during Acute and Convalescent Phases // Clinical and diagnostic laboratory immunology. 2002. Р. 1372–1375.
9. Cinti P., Pretagostini R., Arpino A. et al. Evaluation
10. of pretransplant immunologic status in kidney-trans- plant recipientsby panel reactive antibody and soluble CD30 determinations // Transplantation. 2005. Vol. 79. Р. 1154–1156.
11. Del Prete G., De Carli M., Almerigogna F. et al. Preferen- tial expression of CD30 by human CD 4+ T cells produs- ing Th2-type cytokines // FASEB J. 1995. Vol. 9. Р. 81–86.
12. Fabrega E., Unzueta M.G., Cobo M. Value of soluble CD30 in liver transplantation // Transp. Рroc. 2007. Vol. 39 (7). Р. 2295–2296.
13. Golocheikine A.S., Saini D., Ramachandran S. at al. Sol- uble CD30 levels as a diagnostic marker for bronchiolitis obliteranse syndrome following human lung transplanta- tion // Transplant. Immunol. 2008. Vol. 18. Р. 260–263.
14. Kim K.H., Oh E.J., Jung E.S. et al. Evaluation of pre- and posttransplantation serum interferon-gamma and soluble CD30 for predicting liver allograft rejection // Transp. Proc. 2006. Vol. 38 (5). Р. 1429–1431.
15. Matinlauri I. et al. High serum soluble CD30 does not predict acute rejection in liver transplant patients // Transp. Рroc. 2006. Vol. 38. Р. 3601–3604.
16. Nikaein A., Spiridon C., Hunt J. et al. Pre-transplant level of soluble CD30 is associated with infection after heart transplantation // Clin. Transplant. 2007. Vol. 21. Р. 744–747.
17. Pelzl S., Opelz G., Weisel M. et al. Soluble CD30 as a predictor of kidney graft outcome // Transplantation. 2002. Vol. 73. Р. 3–6.
18. Rajakariar R., Jivanji N., Varagunam L. et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection // Am. J. Transpl. 2005. Vol. 5. Р. 1922–1925.
19. Shevchenko О.P., Pitshulina M.E., Gichkun O.E. et al. Plasma levels of soluble CD30 and neopterin in pediatric living donors liver transplantation // 2010, Vancouver, Canada.
20. Shevchenko O.P., Tsirulnikova O.M., Gichkun O.E. et al. Plasma levels of soluble CD30 and CD40L in pediatric patients after liver transplantation // 21st International Congress of Clinical Chemistry and Laboratory Medi- cine, 15–19 May, 2011, Berlin, Germany.
21. Truong D.Q., Darwish A.A., Gras J. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement // Transpl. Im- munol. 2007. Vol. 17. Р. 283–287.
Review
For citations:
Shevchenko O.P., Tsirulnikova O.M., Olefirenko G.A., Pishchulina M.E., Tsirulnikova I.E., Bugrov A.V., Andrianova A.A., Gautier S.V. PLASMA LEVEL OF SOLUBLE CD30 IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT PATIENT. Russian Journal of Transplantology and Artificial Organs. 2011;13(4):37-42. (In Russ.) https://doi.org/10.15825/1995-1191-2011-4-37-42
Views:
824
Email this article 